Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 6 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Alaunos Therapeutics, Inc. | 43,872 | reported | 12 Jan 2026 | tx 21+1,453,472 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Jan 2026 | GRANT_AWARD | Alaunos Therapeutics, Inc. | 5,622 | 2.89 USD | |
| 21 Nov 2025 | GRANT_AWARD | Alaunos Therapeutics, Inc. | 5,142 | 3.16 USD | |
| 03 Jul 2025 | GRANT_AWARD | Alaunos Therapeutics, Inc. | 4,050 | 0.00 USD | |
| 03 Jul 2025 | GRANT_AWARD | Alaunos Therapeutics, Inc. | 6,400 | 0.00 USD | deriv |
| 13 Apr 2025 | GRANT_AWARD | Alaunos Therapeutics, Inc. | 20,804 | 2.92 USD | |
| 11 Apr 2025 | PURCHASE | Alaunos Therapeutics, Inc. | 500 | 2.76 USD | deriv |
| 24 Jun 2025 | PURCHASE | Alaunos Therapeutics, Inc. | 600 | 4.49 USD | deriv |
| 13 Apr 2025 | GRANT_AWARD | Alaunos Therapeutics, Inc. | 20,804 | 2.92 USD | |
| 11 Apr 2025 | PURCHASE | Alaunos Therapeutics, Inc. | 500 | 2.76 USD | derivfirst after silence |
| 06 Jun 2024 | GRANT_AWARD | Alaunos Therapeutics, Inc. | 12,800 | 0.00 USD | deriv |
| 06 Jun 2023 | GRANT_AWARD | Alaunos Therapeutics, Inc. | 100,000 | 0.00 USD | deriv |
| 29 Nov 2022 | PURCHASE | Alaunos Therapeutics, Inc. | 750,000 | 0.65 USD | first after silence |
| 22 Jun 2022 | GRANT_AWARD | Alaunos Therapeutics, Inc. | 40,000 | 0.00 USD | |
| 22 Jun 2022 | GRANT_AWARD | Alaunos Therapeutics, Inc. | 100,000 | 0.00 USD | deriv |
| 22 Jun 2022 | GRANT_AWARD | Alaunos Therapeutics, Inc. | 40,000 | 0.00 USD | |
| 22 Jun 2022 | GRANT_AWARD | Alaunos Therapeutics, Inc. | 100,000 | 0.00 USD | deriv |
| 02 Sept 2021 | PURCHASE | Alaunos Therapeutics, Inc. | 20,508 | 1.73 USD | |
| 02 Sept 2021 | PURCHASE | Alaunos Therapeutics, Inc. | 54,492 | 1.73 USD | |
| 04 Mar 2021 | GRANT_AWARD | Alaunos Therapeutics, Inc. | 2,500 | 0.00 USD | |
| 04 Mar 2021 | GRANT_AWARD | Alaunos Therapeutics, Inc. | 18,750 | 0.00 USD | deriv |
| 04 Mar 2021 | GRANT_AWARD | Alaunos Therapeutics, Inc. | 150,000 | 0.00 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 11 Apr 2025.